What is PANDA-S?

Researchers from the PANDA-S research study team will use the results to help better support General Practitioners (GPs) and Physiotherapists in the decisions they make about the best and most timely treatments for people with shoulder pain. 

Did you know that in England, 1.5 million people visit their GP with shoulder pain every year? Out of those 1.5 million, most recover quickly, however 40% of people will suffer with shoulder pain which lasts longer than 6 months, affecting their sleep, work and everyday life. 

This study aims to look at a new way of helping GPs and Physiotherapists decide which type of treament is best to use for each patient. 

The PANDA-S research study will be collecting individual patient experiences of shoulder pain. If a patient has seen their GP for shoulder pain, then they may be asked if they would like to learn more about the study. Our research team will then contact the patient, asking them to take part. They'll then be asked to complete a series of questionnaires over a three-year period. They may also be invited to take part in a interview, or to record their experiences using a smartphone app or using a text messaging service. Patients can also be identified through self-referral to physiotherapy.

By participating in the study, participants will help to;

  • Improve information for patients with shoulder pain about its possible cause 
  • Help doctors and physiotherapists to better advise patients with shoulder pain which treatment is best for them 
  • Improve treatment options and reduce uneccessary tests or treatments in those who don't need them 
  • Reduce long-term pain, disability, and work loss due to shoulder pain 

Who is organising the study? 

The Research Institue for Primary Care and Health Sciences at Keele University is leading the study, together with the Keele Clinical Trials Unit (CTU). The research team at Keele will be working in collaboration with a team at the University of Oxford. 

Keele's Clinical Trials Unit specialises in the development and delivery of high-quality research studies. It is a UKCRC registered Clinical Trials Unit. You can find out more by visiting their website

This study has been funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research programme (RP-PG-0615-20002) and Arthritis Research UK.

Study participants will be informed about the PANDA-S research study findings through newsletters, leaflets and posters in participating GP surgeries, participating self-referral physiotherapy clinics and via the Keele University website. Results may take 2 to 3 years to become available once we have finished the study. We plan to present results at medical meetings and conferences, and to publish results through medical journals. You will not be personally identifiable in these presentations or publications. 

The Research Institute for Primary Care and Health Sciences at Keele University is organising this study, together with Keele Clinical Trials Unit (CTU). The research team at Keele is working in collaboration with a research team at the University of Oxford.

What is Keele Clinical Trials Unit (CTU)?

Keele CTU specialises in the development and delivery of high-quality research studies. Keele CTU is a UKCRC registered Clinical Trials Unit. Please go to https://www.keele.ac.uk/kctu/ to find out more about Keele CTU.

To protect your interests, all research in the NHS is looked at by an independent group of people, called a Research Ethics Committee. This study has been reviewed and given favourable opinion by Yorkshire & The Humber: Sheffield Research Ethics Committee. The study has also been reviewed by scientific experts on behalf of the National Institute of Health Research (NIHR), who assessed it before awarding funding.

If you have been invited to take part in the PANDA-S research study it is because you have recently been to see your participating doctor or physiotherapist about your shoulder pain and indicated that you were happy to receive further information about the research. 

If you would like to know more about this study, or have any questions, please contact the Keele Clinical Trials Unit by calling 01782 732950 (office hours are Monday-Friday, 9am-5pm). Alternatively you can email sch-tr.pandasstudy@nhs.net